Second line treatment for EGFR wild-type advanced NSCLC: The Jury is Still Out

U. Dafni, D. Karlis, E. Smit, S. Peters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)314-315
JournalLung Cancer
Volume84
Issue number3
DOIs
Publication statusPublished - 2014

Cite this